Related Experiment Video
Updated: May 17, 2026

A Simple and Rapid Method for Simultaneous Isolation of Primary Islets and Primary Pancreatic Acinar Cells from Mice
Published on: January 9, 2026
Recent advances in autoimmune pancreatitis
Terumi Kamisawa1, Taku Tabata, Seiichi Hara
1Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital Tokyo, Japan.
Autoimmune pancreatitis (AIP) has two types: Type-1 (LPSP) and Type-2. Steroid therapy is effective for both, with specific protocols for oral prednisolone to manage symptoms and prevent relapse.
Area of Science:
- Gastroenterology
- Immunology
- Pathology
Background:
- Autoimmune pancreatitis (AIP) is increasingly recognized with two distinct histological subtypes: Type-1 (lymphoplasmacytic sclerosing pancreatitis - LPSP) and Type-2.
- Type-1 AIP is characterized by lymphoplasmacytic infiltration and IgG4 elevation, while Type-2 AIP shows neutrophilic infiltration of pancreatic ducts.
- Geographical variations exist, with Type-1 AIP predominant in Japan and Korea, and Type-2 AIP more frequently observed in Western countries.
Purpose of the Study:
- To delineate the key differences between Type-1 and Type-2 autoimmune pancreatitis.
- To outline the international consensus diagnostic criteria for AIP.
- To describe the standard steroid therapy protocols for managing AIP.
Main Methods:
- Histopathological classification differentiating Type-1 (LPSP) and Type-2 AIP based on characteristic inflammatory cell infiltrates.
- Application of international consensus diagnostic criteria incorporating five cardinal features.
- Clinical observation of patient demographics, associated conditions, and treatment responses.
Main Results:
- Type-2 AIP patients are generally younger, less likely to have elevated serum IgG4, and more prone to acute pancreatitis and ulcerative colitis compared to Type-1 patients.
- Type-1 AIP is associated with sclerosing extrpancreatic diseases, unlike Type-2 AIP.
- Steroid therapy, particularly oral prednisolone, demonstrates significant clinical, morphological, and serological efficacy in AIP management.
Conclusions:
- Distinguishing between Type-1 and Type-2 AIP is crucial for understanding disease behavior and prognosis.
- International consensus criteria facilitate accurate diagnosis of both AIP subtypes.
- Steroid therapy, with a defined tapering regimen, is the cornerstone treatment for autoimmune pancreatitis, effectively managing symptoms and preventing relapses.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Pathophysiology

